Diabetes and the vitamin D connection

Current Diabetes Reports

Volumn 8, Issue 5, 2008, Pages 393-398

  Holick, Michael F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; GLUCOCORTICOID; METFORMIN; PLACEBO; REPAGLINIDE; ROSIGLITAZONE; VITAMIN D; VITAMIN;

ABSENCE OF SIDE EFFECTS; CALCIUM INTAKE; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; EXERCISE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK ASSESSMENT; SINGLE DRUG DOSE; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ARTICLE; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM;

BLOOD GLUCOSE; CALCIUM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 58149395018     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0068-0     Document Type: Review

References (50)

1. Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
2. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005, 26:662-687.
3. Li YC, Kong J, Wei M, et al.: 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
4. Bland R, Markovic D, Hills CE, et al.: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004, 89-90:121-125.
5. Liu PT, Stenger S, Li H, et al.: Toll-like receptor Triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 3:1770-1773.
6. Feldman D, Zhao XY, Krishnan AV: Vitamin D and prostate cancer. Endocrinology 2000, 141:5-9.
7. Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 70:2861-2869.
8. Gorham ED, Garland CF, Garland FC, et al.: Optimal vitamin D status for colorectal cancer prevention: A quantitative meta-analysis. Am J Prev Med 2007, 32:210-216.
9. Moan J, Porojnicu AC, Dahlback A, Setlow RB: Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A 2008, 105:668-673.
10. Pilz S, Dognig H, Winklhofer-Roob B, et al.: Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 2008, 17:1228-1233.
11. Heaney RP: Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80(Suppl):1706S-1709S.
12. Wang TJ, Pencina MJ, Booth SL, et al.: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
13. Dobnig H, Pilz S, Scharnagl H, et al.: Independent association of low serum 25-hydroxyvitami D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
14. Ponsonby AL, Lucas RM, van der Mei IA: UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 2005, 81:1267-1275.
15. Merlino LA, Curtis J, Mikuls TR, et al.: Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum 2004, 50:72-77.
16. Hypponen E, Laara E, Jarvelin MR, Virtanen SM: Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001, 358:1500-1503.
17. Penna G, Amuchastegui S, Giarratana N, et al.: 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007, 178:145-153.
18. Inomata S, Kadowaki S, Yamatani T, et al.: Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1986, 1:187-192.
19. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
20. Mohr SB, Garland CF, Gorham ED, Garland FC: The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008 June 12 (Epub ahead of print).
21. Karvonen M, Viik-Kajander M, Molchanova E, et al.: Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000, 23:1516-1526.
22. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group [no authors listed]. Diabetologia 1999, 42:51-54.
23. Stene LC, Joner G: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A large, population-based, case-control study. Am J Clin Nutr 2003, 78:1128-1134.
24. Stene LC, Barriga K, Norris JM, et al.: Perinatal factors and development of islet autoimmunity in early childhood: The diabetes autoimmunity study in the young. Am J Epidemiol 2004, 160:3-10.
25. Scragg R, Holdaway I, Singh V, et al.: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995, 27:181-188.
26. Isaia G, Giorgino R, Adami S: High prevalence of hypovitaminosis D in female type 2 diabetic population [letter]. Diabetes Care 2001, 24:1496.
27. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
28. Ford ES, Ajani UA, McGurie LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230.
29. Gedik O, Akalin S: Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986, 29:142-145.
30. Orwoll E, Riddle M, Prince M: Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994, 59:1083-1087.
31. Borissova AM, Tankova T, Kirilov G, et al.: The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57:258-261.
32. Kumar S, Davies M, Zakaria Y, et al.: Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 1994, 70:440-443.
33. Pittas AG, Dawson-Hughes B, Li T, et al.: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29:650-656.
34. Hypponen E, Power C: Vitamin D status and glucose homeostasis in the 1958 British birth cohort. Diabetes Care 2006, 2244-2246.
35. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
36. Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, and Institute of Medicine: Vitamin D. In Dietary Reference Intakes: For Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 1999:250-287.
37. Holick MF, Biancuzzo RM, Chen TC, et al.: Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
38. Vieth R, Chan PCR, MacFarlane GD: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
39. Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 1998, 351:805-806.
40. Chapuy MC, Schott AM, Garnero P, et al.: Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 1996, 81:1129-1133.
41. Holick MF, Siris ES, Binkley N, et al.: Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215-3224.
42. Heaney RP, Dowell MS, Hale CA, Bendich A: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142-146.
43. Zhou C, Assem M, Tay JC, et al.: Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703-1712.
44. Clemens TL, Henderson SL, Adams JS, Holick MF: Increased skin pigment reduces the capacity of skin to synthesis vitamin D3. Lancet 1982, 1:74-76.
45. Wortsman J, Matsuoka LY, Chen TC, et al.: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693. (Published erratum appears in Am J Clin Nutr 2003, 77:1342.)
46. Tang HM, Cole DEC, Rubin LA, et al.: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
47. Armas LA, Hollis B, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
48. Schwalfenberg G: Vitamin D and diabetes. Improvement of glycemic control with vitamin D3 repletion. Can Fam Physician 2008, 54:864-866.
49. Stene LC, Ulriksen E, Magnus P, Joner G: Use of cod liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia 2000, 43:1093-1098.
50. Jun HS, Yoon JW: A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003, 19:8-31.